Inflammatory bowel disease and the risk of osteoporosis and fracture

Maturitas

Volumn 76, Issue 4, 2013, Pages 315-319

  Targownik, Laura E ^a   Bernstein, Charles N ^a   Leslie, William D ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Bone mineral density; Crohn's disease; Fracture; Inflammatory bowel disease; Osteoporosis; Ulcerative colitis

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CORTICOSTEROID; RISEDRONIC ACID; VITAMIN D;

BODY MASS; BONE MINERAL; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; DIETARY INTAKE; DRUG USE; DUAL ENERGY X RAY ABSORPTIOMETRY; ENTERITIS; FRAGILITY FRACTURE; HUMAN; MALABSORPTION; OSTEOLYSIS; OSTEOPOROSIS; PREVALENCE; REVIEW; RISK FACTOR; SCREENING TEST; ULCERATIVE COLITIS; VITAMIN SUPPLEMENTATION;

BONE MINERAL DENSITY; CROHN'S DISEASE; FRACTURE; INFLAMMATORY BOWEL DISEASE; OSTEOPOROSIS; ULCERATIVE COLITIS;

ADRENAL CORTEX HORMONES; BONE DENSITY; DIET; FRACTURES, BONE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALABSORPTION SYNDROMES; OSTEOPOROSIS; THINNESS;

EID: 84888029818     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2013.09.009     Document Type: Review

References (70)

1. L. Peyrin-Biroulet, E.V. Loftus Jr., J.F. Colombel, and W.J. Sandborn The natural history of adult Crohn's disease in population-based cohorts Am J Gastroenterol 105 2 2010 289 297 [Epub 2009/10/29]
2. I.C. Solberg, I. Lygren, and J. Jahnsen Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study) Scand J Gastroenterol 44 4 2009 431 440 [Epub 2008/12/23]
3. I.C. Solberg, M.H. Vatn, and O. Hoie Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study Clin Gastroenterol Hepatol 5 12 2007 1430 1438 [Epub 2007/12/07]
4. C.N. Bernstein, J.F. Blanchard, P. Rawsthorne, and A. Wajda Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study Am J Epidemiol 149 10 1999 916 924 [Epub 1999/05/26]
5. C.N. Bernstein, A. Wajda, and L.W. Svenson The epidemiology of inflammatory bowel disease in Canada: a population-based study Am J Gastroenterol 101 7 2006 1559 1568 [Epub 2006/07/26]
6. A. Ekbom, C.G. Helmick, M. Zack, L. Holmberg, and H.O. Adami Survival and causes of death in patients with inflammatory bowel disease: a population-based study Gastroenterology 103 3 1992 954 960 [Epub 1992/09/01]
7. T. Jess, M. Frisch, and J. Simonsen Trends in overall and cause-specific mortality among patients with inflammatory bowel disease from 1982 to 2010 Clin Gastroenterol Hepatol 11 1 2013 43 48 [Epub 2012/10/02]
8. E.V. Loftus Jr., M.D. Silverstein, W.J. Sandborn, W.J. Tremaine, W.S. Harmsen, and A.R. Zinsmeister Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival Gut 46 3 2000 336 343 [Epub 2000/02/15]
9. E.V. Loftus Jr., M.D. Silverstein, W.J. Sandborn, W.J. Tremaine, W.S. Harmsen, and A.R. Zinsmeister Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival Gastroenterology 114 6 1998 1161 1168 [Epub 1998/06/03]
10. J.A. Kanis Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group Osteoporos Int 4 6 1994 368 381 [Epub 1994/11/01]
11. A.C. Looker, E.S. Orwoll, and C.C. Johnston Jr. Prevalence of low femoral bone density in older U.S. adults from NHANES III J Bone Miner Res 12 11 1997 1761 1768 [Epub 1998/02/07]
12. R.A. van Hogezand, and N.A. Hamdy Skeletal morbidity in inflammatory bowel disease Scand J Gastroenterol Suppl 2006 243 2006 59 64 [Epub 2006/06/20]
13. C.N. Bernstein, and W.D. Leslie Review article: osteoporosis and inflammatory bowel disease Aliment Pharmacol Ther 19 9 2004 941 952 [Epub 2004/04/29]
14. C.N. Bernstein, W.D. Leslie, and M.S. Leboff AGA technical review on osteoporosis in gastrointestinal diseases Gastroenterology 124 3 2003 795 841 [Epub 2003/03/04]
15. R.D. Pollak, F. Karmeli, R. Eliakim, Z. Ackerman, K. Tabb, and D. Rachmilewitz Femoral neck osteopenia in patients with inflammatory bowel disease Am J Gastroenterol 93 9 1998 1483 1490 [Epub 1998/09/11]
16. V. Abitbol, C. Roux, and S. Chaussade Metabolic bone assessment in patients with inflammatory bowel disease Gastroenterology 108 2 1995 417 422 [Epub 1995/02/01]
17. W.D. Leslie, N. Miller, L. Rogala, and C.N. Bernstein Body mass and composition affect bone density in recently diagnosed inflammatory bowel disease: the Manitoba IBD Cohort Study Inflamm Bowel Dis 15 1 2009 39 46 [Epub 2008/07/16]
18. E.J. Schoon, A.B. van Nunen, R.S. Wouters, R.W. Stockbrugger, and M.G. Russel Osteopenia and osteoporosis in Crohn's disease: prevalence in a Dutch population-based cohort Scand J Gastroenterol Suppl 232 2000 43 47 [Epub 2001/03/10]
19. P.J. Pickhardt, B.D. Pooler, T. Lauder, A.M. del Rio, R.J. Bruce, and N. Binkley Opportunistic screening for osteoporosis using abdominal computed tomography scans obtained for other indications Ann Intern Med 158 8 2013 588 595 [Epub 2013/04/17]
20. H. Tilg, A.R. Moschen, A. Kaser, A. Pines, and I. Dotan Gut, inflammation and osteoporosis: basic and clinical concepts Gut 57 5 2008 684 694 [Epub 2008/04/15]
21. C. Abraham, and J.H. Cho Inflammatory bowel disease N Engl J Med 361 21 2009 2066 2078 [Epub 2009/11/20]
22. B.F. Boyce, and L. Xing Biology of RANK, RANKL, and osteoprotegerin Arthritis Res Ther 9 Suppl. 1 2007 S1 [Epub 2007/07/20]
23. A.R. Moschen, A. Kaser, and B. Enrich The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss Gut 54 4 2005 479 487 [Epub 2005/03/09]
24. C.N. Bernstein, M. Sargent, and W.D. Leslie Serum osteoprotegerin is increased in Crohn's disease: a population-based case control study Inflamm Bowel Dis 11 4 2005 325 330 [Epub 2005/04/02]
25. N. Franchimont, C. Reenaers, and C. Lambert Increased expression of receptor activator of NF-kappaB ligand (RANKL), its receptor RANK and its decoy receptor osteoprotegerin in the colon of Crohn's disease patients Clin Exp Immunol 138 3 2004 491 498 [Epub 2004/11/17]
26. S. Ghosh, S. Cowen, W.J. Hannan, and A. Ferguson Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis Gastroenterology 107 4 1994 1031 1039 [Epub 1994/10/01]
27. S.G. Veerappan, C.A. O'Morain, J.S. Daly, and B.M. Ryan Review article: the effects of antitumour necrosis factor-alpha on bone metabolism in inflammatory bowel disease Aliment Pharmacol Ther 33 12 2011 1261 1272 [Epub 2011/04/28]
28. L.E. Targownik, W.D. Leslie, and R. Carr Longitudinal change in bone mineral density in a population-based cohort of patients with inflammatory bowel disease Calcif Tissue Int 91 5 2012 356 363 [Epub 2012/09/18]
29. L.E. Targownik, C.N. Bernstein, Z. Nugent, and W.D. Leslie Inflammatory bowel disease has a small effect on bone mineral density and risk for osteoporosis Clin Gastroenterol Hepatol 11 3 2013 278 285 [Epub 2012/10/30]
30. J. Jones, E.V. Loftus Jr., and R. Panaccione Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease Clin Gastroenterol Hepatol 6 11 2008 1218 1224 [Epub 2008/09/19]
31. T. Sipponen, P. Karkkainen, and E. Savilahti Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn's disease and histological findings Aliment Pharmacol Ther 28 10 2008 1221 1229 [Epub 2008/08/30]
32. K. Vagianos, S. Bector, J. McConnell, and C.N. Bernstein Nutrition assessment of patients with inflammatory bowel disease JPEN J Parenter Enteral Nutr 31 4 2007 311 319 [Epub 2007/06/28]
33. B.J. Geerling, A. Badart-Smook, R.W. Stockbrugger, and R.J. Brummer Comprehensive nutritional status in recently diagnosed patients with inflammatory bowel disease compared with population controls Eur J Clin Nutr 54 6 2000 514 521 [Epub 2000/07/06]
34. W.D. Leslie, N. Miller, L. Rogala, and C.N. Bernstein Vitamin D status and bone density in recently diagnosed inflammatory bowel disease: the Manitoba IBD Cohort Study Am J Gastroenterol 103 6 2008 1451 1459 [Epub 2008/04/22]
35. E.L. Krawitt, W.L. Beeken, and C.D. Janney Calcium absorption in Crohn's disease Gastroenterology 71 2 1976 251 254 [Epub 1976/08/01]
36. R.H. Driscoll Jr., S.C. Meredith, M. Sitrin, and I.H. Rosenberg Vitamin D deficiency and bone disease in patients with Crohn's disease Gastroenterology 83 6 1982 1252 1258 [Epub 1982/12/01]
37. J.A. Silvennoinen, T.J. Karttunen, S.E. Niemela, J.J. Manelius, and J.K. Lehtola A controlled study of bone mineral density in patients with inflammatory bowel disease Gut 37 1 1995 71 76 [Epub 1995/07/01]
38. Recommendations for the prevention and treatment of glucocorticoid- induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis Arthritis Rheum 44 7 2001 1496 1503 [Epub 2001/07/24]
39. J. Silvennoinen, C. Lamberg-Allardt, M. Karkkainen, S. Niemela, and J. Lehtola Dietary calcium intake and its relation to bone mineral density in patients with inflammatory bowel disease J Intern Med 240 5 1996 285 292 [Epub 1996/11/01]
40. C.N. Bernstein, J.F. Blanchard, C. Metge, and M. Yogendran The association between corticosteroid use and development of fractures among IBD patients in a population-based database Am J Gastroenterol 98 8 2003 1797 1801 [Epub 2003/08/09]
41. L.E. Targownik, H. Singh, Z. Nugent, and C.N. Bernstein Prescription drug use in IBD: a population based study Gastroenterology 140 5(S1) 2011 S778 S779
42. S. Morin, L.M. Lix, M. Azimaee, C. Metge, P. Caetano, and W.D. Leslie Mortality rates after incident non-traumatic fractures in older men and women Osteoporos Int 2010 [Epub 2010/12/17]
43. S.E. Bentler, L. Liu, and M. Obrizan The aftermath of hip fracture: discharge placement, functional status change, and mortality Am J Epidemiol 170 10 2009 1290 1299 [Epub 2009/10/08]
44. C.N. Bernstein, J.F. Blanchard, W. Leslie, A. Wajda, and B.N. Yu The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study Ann Intern Med 133 10 2000 795 799 [Epub 2000/11/21]
45. T. Card, J. West, R. Hubbard, and R.F. Logan Hip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use: a population based cohort study Gut 53 2 2004 251 255 [Epub 2004/01/16]
46. T.P. van Staa, C. Cooper, L.S. Brusse, H. Leufkens, M.K. Javaid, and N.K. Arden Inflammatory bowel disease and the risk of fracture Gastroenterology 125 6 2003 1591 1597 [Epub 2004/01/16]
47. P. Vestergaard, and L. Mosekilde Fracture risk in patients with celiac disease, Crohn's disease, and ulcerative colitis: a nationwide follow-up study of 16,416 patients in Denmark Am J Epidemiol 156 1 2002 1 10 [Epub 2002/06/22]
48. E.V. Loftus Jr., S.J. Achenbach, W.J. Sandborn, W.J. Tremaine, A.L. Oberg, and L.J.III Melton Risk of fracture in ulcerative colitis: a population-based study from Olmsted County, Minnesota Clin Gastroenterol Hepatol 1 6 2003 465 473 [Epub 2004/03/16]
49. E.V. Loftus Jr., C.S. Crowson, W.J. Sandborn, W.J. Tremaine, W.M. O'Fallon, and L.J.III Melton Long-term fracture risk in patients with Crohn's disease: a population-based study in Olmsted County, Minnesota Gastroenterology 123 2 2002 468 475 [Epub 2002/07/30]
50. L.E. Targownik, C.N. Bernstein, and Z. Nugent Inflammatory bowel disease and the risk of fracture after controlling for FRAX J Bone Miner Res 28 5 2013 1007 1013 [Epub 2012/12/15]
51. E.M. Scott, I. Gaywood, and B.B. Scott Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. British Society of Gastroenterology Gut 46 Suppl. 1 2000 i1 i8 [Epub 2000/01/27]
52. A. Atreja, A. Aggarwal, A.A. Licata, and B.A. Lashner Low body mass index can identify majority of osteoporotic inflammatory bowel disease patients missed by current guidelines Sci World J 2012 2012 807438 [Epub 2012/05/31]
53. K.L. Stone, D.G. Seeley, and L.Y. Lui BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures J Bone Miner Res 18 11 2003 1947 1954 [Epub 2003/11/11]
54. S.A. Wainwright, L.M. Marshall, and K.E. Ensrud Hip fracture in women without osteoporosis J Clin Endocrinol Metab 90 5 2005 2787 2793 [Epub 2005/02/25]
55. J.A. Kanis, O. Johnell, A. Oden, H. Johansson, and E. McCloskey FRAX and the assessment of fracture probability in men and women from the UK Osteoporos Int 19 4 2008 385 397 [Epub 2008/02/23]
56. J.A. Kanis, E. McCloskey, H. Johansson, A. Oden, and W.D. Leslie FRAX((R)) with and without bone mineral density Calcif Tissue Int 90 1 2012 1 13 [Epub 2011/11/08]
57. A. Papaioannou, S. Morin, and A.M. Cheung 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary CMAJ: Can Med Assoc J = journal de l'Association medicale canadienne 182 17 2010 1864 1873 [Epub 2010/10/14]
58. J. Compston, A. Cooper, and C. Cooper Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK Maturitas 62 2 2009 105 108 [Epub 2009/01/13]
59. J.R. Goodhand, N. Kamperidis, H. Nguyen, M. Wahed, and D.S. Rampton Application of the WHO fracture risk assessment tool (FRAX) to predict need for DEXA scanning and treatment in patients with inflammatory bowel disease at risk of osteoporosis Aliment Pharmacol Ther 33 5 2011 551 558 [Epub 2011/01/05]
60. J.A. Cauley, A.Z. Lacroix, and L. Wu Serum 25-hydroxyvitamin D concentrations and risk for hip fractures Ann Intern Med 149 4 2008 242 250 [Epub 2008/08/20]
61. A.C. Looker, and M.E. Mussolino Serum 25-hydroxyvitamin D and hip fracture risk in older U.S. white adults J Bone Miner Res 23 1 2008 143 150 [Epub 2007/10/03]
62. R.D. Jackson, A.Z. LaCroix, and M. Gass Calcium plus vitamin D supplementation and the risk of fractures N Engl J Med 354 7 2006 669 683 [Epub 2006/02/17]
63. M.C. Chapuy, M.E. Arlot, and F. Duboeuf Vitamin D3 and calcium to prevent hip fractures in the elderly women N Engl J Med 327 23 1992 1637 1642 [Epub 1992/12/03]
64. C.N. Bernstein, L.L. Seeger, and P.A. Anton A randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: a pilot study Aliment Pharmacol Ther 10 5 1996 777 786 [Epub 1996/10/01]
65. C.N. Bernstein, S. Bector, and W.D. Leslie Lack of relationship of calcium and vitamin D intake to bone mineral density in premenopausal women with inflammatory bowel disease Am J Gastroenterol 98 11 2003 2468 2473 [Epub 2003/11/26]
66. J. Melek, and A. Sakuraba Efficacy and safety of medical therapy for low bone-mineral density in patients with inflammatory bowel disease: a meta-analysis and systematic review Clin Gastroenterol Hepatol 2013 [Epub 2013/08/29]
67. S. Henderson, N. Hoffman, and R. Prince A double-blind placebo-controlled study of the effects of the bisphosphonate risedronate on bone mass in patients with inflammatory bowel disease Am J Gastroenterol 101 1 2006 119 123 [Epub 2006/01/13]
68. S. Palomba, F. Manguso, and F. Orio Jr. Effectiveness of risedronate in osteoporotic postmenopausal women with inflammatory bowel disease: a prospective, parallel, open-label, two-year extension study Menopause 15 4 Pt 1 2008 730 736 [Epub 2008/08/14]
69. K.G. Saag, R. Emkey, and T.J. Schnitzer Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group N Engl J Med 339 5 1998 292 299 [Epub 1998/07/31]
70. V. Abitbol, K. Briot, and C. Roux A double-blind placebo-controlled s tudy of intravenous clodronate for prevention of steroid-induced bone loss in inflammatory bowel disease Clin Gastroenterol Hepatol 5 10 2007 1184 1189 [Epub 2007/08/09]